Cowen biotech surprises for 2020: Alexion patents, hemophilia treatments - Business Insider

A number of surprises could rock the biotech market, so analysts at the investment bank Cowen worked to take them into account before they transpired.

In August, the US Patent and Trademark Office launched a review of the patents for Soliris, Alexion's blockbuster rare blood disease drug, after rival Amgen requested a challenge to the company's patents on the drug. "With a number of other gene therapies for Hemophilia A in or entering clinical trials, why wouldn't patients wait a few years to see if there is one with a better profile? It is hard to see how the adoption of valrox won't be glacial," Cowen analysts noted as the consensus view.

For instance, in defending the $1,000-a-pill price tag of the hepatitis C treatment Sovaldi, Gilead could argue that it was looking to recoup on its investment, which largely included the $11.2 billion acquisition of Pharmasset, the company that initially developed Sovaldi.Despite what the past year has been like for big biotech companies like Celgene, Biogen, Amgen, and Gilead, a surprise that could happen in 2020 might be that these drugmakers make a comeback.

, and the potential to introduce certain strains of bacteria to enhance responses to treatments. Though most research into treatments targeting the microbiome still hasn't made it past early trials, the analysts wrote that the results so far "provide reasons to be encouraged by single-strain approaches in these oncology settings."5.

Portugal Últimas Notícias, Portugal Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Joining a 'mastermind group' could help your business thrive in 2020 — here's how - Business InsiderBeing a solo entrepreneur is a daunting task — but joining a mastermind group can offer some vital support.
Fonte: BusinessInsider - 🏆 729. / 51 Consulte Mais informação »

Early 2020 credit cards checklist: How to decide which to keep - Business InsiderTo evaluate my credit card strategy each year, I look at any changes to my credit cards' benefits and annual fees I don't see the relationship between credit card strategies and this image. They are the devil's instrument designed to trap people into slave like debt servitude. No one can justify usurious interest rates for the sake of ‘convenience’.
Fonte: BusinessInsider - 🏆 729. / 51 Consulte Mais informação »

Self-Help Books To Help Your Business Grow And Thrive In 2020This is a book intended to focus you on finding what Godin calls “the smallest viable audience” for your product, your service or your idea and seeing where that leads. I'm not sure I understand what you're saying. I'm not saying that the book is bad, but I'm saying the author is not a 'professional'. He is a professional. He is not a 'professional'. He has a job and a job.
Fonte: Forbes - 🏆 394. / 53 Consulte Mais informação »

Samsung unveils its new all-screen 8K TV at CES 2020 - Business InsiderThe new Samsung 8K TV has a screen-to-body ratio of almost 99%, which means that the front of the TV is almost entirely screen. Don't me if it ain't OLED. GOAT.
Fonte: BusinessInsider - 🏆 729. / 51 Consulte Mais informação »

Mexico is a top neobank market to watch in 2020 - Business InsiderIn addition to its underbanked conditions, Mexico is a prime market for neobanks due to its favorable regulatory landscape and consumer demographics.
Fonte: BusinessInsider - 🏆 729. / 51 Consulte Mais informação »